Keyphrases
Non-variceal Upper Gastrointestinal Bleeding
100%
Endoscopic Surgery
100%
Over-the-scope Clip
100%
Confidence Interval
89%
Malignant Biliary Obstruction
55%
Meta-analysis
50%
Patient-Reported Outcomes Measurement Information System (PROMIS)
50%
Forest Plot
50%
First-line Therapy
50%
Fine-needle Aspiration Biopsy
50%
Solid Pancreatic Lesions
50%
Rapid On-site Evaluation
50%
Telecytology
50%
Biliary Drainage
50%
Telemedicine
50%
Biopsy Specimen
50%
Digestive Diseases
50%
In-room
50%
Gastroenterology Practice
50%
EUS-guided FNA
50%
Prospective Cohort Study
50%
Metaanalysis
50%
Systematic Meta-analysis
50%
Cytotechnologist
50%
No-show Rate
50%
Between-group
50%
Endoscopic Retrograde Cholangiopancreatography
50%
Risk Ratio
43%
Rebleeding
31%
No-show
30%
Vascular Embolization
25%
Hemostasis
25%
Adverse Events
24%
Technical Success
21%
Low-income
20%
Pre-pandemic
20%
Latinx
20%
Access to Care
20%
Diagnostic Performance
18%
Endoscopic Ultrasound-guided Fine-needle Aspiration (EUS-FNA)
18%
Consensus Criteria
16%
Cotton
16%
Statistical Analysis
14%
Clinical Efficacy
14%
Surgically Altered Anatomy
14%
Normal Anatomy
14%
Random Effects Model
13%
I2 Statistic
13%
Need for Surgery
12%
Readmission Rates
12%
Medicine and Dentistry
Meta-Analysis
100%
Systematic Review
100%
Endoscopic Retrograde Cholangiopancreatography
83%
Cohort Analysis
62%
Cholestasis
55%
Telemedicine
50%
Patient-Reported Outcome
50%
Fine-Needle Aspiration
50%
Gastroenterology
50%
Diagnosis
50%
Premedication
50%
Infliximab
50%
Infusion
50%
Biliary Tract Drainage
50%
Upper Gastrointestinal Bleeding
50%
Prospective Cohort Study
50%
Patient with Inflammatory Bowel Disease
50%
Adverse Event
34%
Anatomy
33%
Bleeding
30%
Endoscopy
20%
Blood Stasis
20%
Health Care
20%
Embolization
20%
Random Effects Model
18%
Malignant Neoplasm
12%
Tail
12%
COVID-19
12%
Social Distancing
12%
Univariate Analysis
12%
Arm
12%
Quality of Life
11%
Odds Ratio
11%
Symptom
11%
Logistic Regression Analysis
10%
Multivariate Analysis
10%
Endoscopic Therapy
10%
Retrospective Study
10%
Health Care Disparity
10%
Surgical Risk
10%
Subgroup Analysis
8%
Patient Experience
5%
Acute Pancreatitis
5%
Common Bile Duct Stone
5%
Pancreas Cancer
5%
Primary Sclerosing Cholangitis
5%
Health Care Cost
5%
McNemar Test
5%
Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
5%
